Neurocrine Biosciences
NBIX
#1384
Rank
NZ$26.56 B
Marketcap
NZ$266.40
Share price
0.83%
Change (1 day)
15.54%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company